Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleHypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT06435260 - No phaseTaking peoplePatient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 164
- Run by
- Beijing Daxiang Biotech Co., Ltd
See details and how to joinNCT07683845 - No phaseTaking peopleA Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,030
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07561814 - Phase 1Taking peopleA Study of DEG6498 in Participants With Solid Tumors
- Where
- Beijing, Guangzhou
- Age
- 18 years and over
- People
- 100
- Run by
- Degron Therapeutics Co.
See details and how to joinNCT07244835 - No phaseTaking peopleAssociation Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
- Where
- Changsha, Shanghai, Xi’an
- Age
- 18 years and over
- People
- 320
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07529626 - No phaseTaking peopleSpatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07670286 - Early phase 1Taking peopleA Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 24
- Run by
- Ruijin Hospital
See details and how to joinNCT07649928 - Phase 2Taking peopleAn Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer
- Where
- Nanjing, Tianjin
- Age
- 18 years to 75 years
- People
- 92
- Run by
- Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07589569 - Phase 1Taking peopleSafety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
- Where
- Chongqing, Shanghai, Suzhou, Tianjin, Zhengzhou
- Age
- 18 years to 80 years
- People
- 58
- Run by
- Chengdu New Radiomedicine Technology Co. LTD.
See details and how to joinNCT06278454 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 178
- Run by
- Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT07610798 - Phase 1Not yet taking people in ChinaPeptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Sichuan University
See details and how to joinNCT07637786 - No phaseTaking peopleAssessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
- Where
- Shenyang
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Yu Shi
See details and how to joinNCT06849063 - Phase 2Not yet taking people in ChinaA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- Where
- Beijing, Harbin
- Age
- 18 years to 80 years
- People
- 227
- Run by
- GV20 Therapeutics
See details and how to joinNCT07623642 - Phase 3Taking peopleRadiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 288
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07632118 - Phase 1/2Taking peopleDual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Beijing Biotech
See details and how to joinNCT07627711 - Phase 2Taking peopleHRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 133
- Run by
- Zhejiang University
See details and how to joinNCT06770452 - Phase 2Taking peopleIBI343 in Combination Therapy for Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 389
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07483554 - Phase 1Not yet taking people in ChinaStudy of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 198
- Run by
- Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
See details and how to joinNCT07624214 - No phaseTaking peopleClinical Application of PET Imaging Targeting MSLN in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years to 65 years
- People
- 100
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06843629 - Phase 2Taking peopleHRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Ruijin Hospital
See details and how to joinNCT06587061 - Phase 2Taking peopleHRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Ruijin Hospital
See details and how to joinNCT07131514 - Phase 1/2Taking peopleExploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 130
- Run by
- Fudan University
See details and how to joinNCT06427239 - Early phase 1Taking peopleCDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT06937567 - No phaseTaking peopleMulticentric Database for KRAS Mutant Pancreatic Cancer
- Where
- Shanghai
- People
- 1,000
- Run by
- Fudan University
See details and how to joinNCT07557849 - Phase 1/2Taking peopleA Study of JMT203 in Patients With Cancer Cachexia
- Where
- Zhejiang
- Age
- 18 years and over
- People
- 307
- Run by
- Shanghai JMT-Bio Inc.
See details and how to joinNCT06868849